Catherine Amlie-Lefond1, Don Gilden2. 1. Department of Neurology, Seattle Children's Hospital, University of Washington, Seattle, Washington. Electronic address: calefond@seattlechildrens.org. 2. Departments of Neurology and Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado.
Abstract
BACKGROUND: Varicella zoster virus (VZV) is a neurotropic, exclusively human herpesvirus. Primary infection causes varicella (chickenpox), after which the virus becomes latent in ganglionic neurons along the entire neuraxis. As cell-mediated immunity to VZV declines with advancing age and immunosuppression, VZV reactivates to produce zoster (shingles). One of the most serious complications of zoster is VZV vasculopathy. METHODS: We reviewed recent studies of stroke associated with varicella and zoster, how VZV vasculopathy is verified virologically, vaccination to prevent varicella and immunization to prevent zoster, and VZV in giant cell arteritis (GCA). FINDINGS: We report recent epidemiological studies revealing an increased risk of stroke after zoster; the clinical, laboratory, and imaging features of VZV vasculopathy; that VZV vasculopathy is confirmed by the presence of either VZV DNA or anti-VZV IgG antibody in cerebrospinal fluid; special features of VZV vasculopathy in children; vaccination to prevent varicella and immunization to prevent zoster; and the latest evidence linking VZV to GCA. CONCLUSION: In children and adults, VZV is a common cause of stroke.
BACKGROUND:Varicella zoster virus (VZV) is a neurotropic, exclusively humanherpesvirus. Primary infection causes varicella (chickenpox), after which the virus becomes latent in ganglionic neurons along the entire neuraxis. As cell-mediated immunity to VZV declines with advancing age and immunosuppression, VZV reactivates to produce zoster (shingles). One of the most serious complications of zoster is VZV vasculopathy. METHODS: We reviewed recent studies of stroke associated with varicella and zoster, how VZV vasculopathy is verified virologically, vaccination to prevent varicella and immunization to prevent zoster, and VZV in giant cell arteritis (GCA). FINDINGS: We report recent epidemiological studies revealing an increased risk of stroke after zoster; the clinical, laboratory, and imaging features of VZV vasculopathy; that VZV vasculopathy is confirmed by the presence of either VZV DNA or anti-VZV IgG antibody in cerebrospinal fluid; special features of VZV vasculopathy in children; vaccination to prevent varicella and immunization to prevent zoster; and the latest evidence linking VZV to GCA. CONCLUSION: In children and adults, VZV is a common cause of stroke.
Authors: Michael S Simberkoff; Robert D Arbeit; Gary R Johnson; Michael N Oxman; Kathy D Boardman; Heather M Williams; Myron J Levin; Kenneth E Schmader; Lawrence D Gelb; Susan Keay; Kathleen Neuzil; Richard N Greenberg; Marie R Griffin; Larry E Davis; Vicki A Morrison; Paula W Annunziato Journal: Ann Intern Med Date: 2010-05-04 Impact factor: 25.391
Authors: Werner J D Ouwendijk; Alexander Choe; Maria A Nagel; Don Gilden; Albert D M E Osterhaus; Randall J Cohrs; Georges M G M Verjans Journal: J Virol Date: 2012-06-27 Impact factor: 5.103
Authors: M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden Journal: Neurology Date: 2008-03-11 Impact factor: 9.910
Authors: Elena Miravet; Nasuda Danchaivijitr; Helen Basu; Dawn E Saunders; Vijeya Ganesan Journal: Dev Med Child Neurol Date: 2007-06 Impact factor: 5.449
Authors: Sarah K Lants; Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Manus J Donahue; Matthew R Fusco Journal: World Neurosurg Date: 2017-12-20 Impact factor: 2.104
Authors: L Gerstl; M V Bonfert; T Nicolai; M Dieterich; C Adamczyk; F Heinen; M Olivieri; M Steinlin Journal: Nervenarzt Date: 2017-12 Impact factor: 1.214